Novel octahedral Pt(IV) complex with di- n-propyl-( S,S)-ethylenediamine- N,N′-di-2-(3-cyclohexyl)propanoato ligand exerts potent immunomodulatory effects
We have recently reported that a novel octahedral Pt(IV) complex with di- n-propyl-( S,S)-ethylenediamine- N,N′-di-2-(3-cyclohexyl)propanoato ligand has a potent cytotoxic effect on glioma, melanoma and fibrosarcoma cell lines. In this work, we investigated the influence of the Pt(IV) compound on im...
Saved in:
Published in | European journal of medicinal chemistry Vol. 47; no. 1; pp. 194 - 201 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier Masson SAS
2012
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We have recently reported that a novel octahedral Pt(IV) complex with di-
n-propyl-(
S,S)-ethylenediamine-
N,N′-di-2-(3-cyclohexyl)propanoato ligand has a potent cytotoxic effect on glioma, melanoma and fibrosarcoma cell lines. In this work, we investigated the influence of the Pt(IV) compound on immune cells. We determined its effect on the viability of spleen cells and lymph node cells and on their capability to produce interferon (IFN)-γ and interleukin (IL)-17. Also, we researched the compound’s impact on peritoneal macrophages and generation of NO in these cells. Our results show that the complex has limited influence on cell viability of immune cells, but profound inhibitory effect on the production of examined immune mediators. These results are valuable as they show that the novel Pt(IV) complex applied in concentrations which are effective against tumor cells do not affect immune cell viability. Moreover, they also imply that the complex has immunomodulatory properties.
[Display omitted]
► [Pt(L)Cl
4] inhibits tumor, but not immune cell viability. ► [Pt(L)Cl
4] inhibits cytokine and nitric oxide generation by immune cells. ► [Pt(L)Cl
4] has tumoricidal and immunomodulatory, but not immunosuppressive effect. ► These features promote [Pt(L)Cl
4] as a likely anticancer and immunomodulatory drug. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0223-5234 1768-3254 |
DOI: | 10.1016/j.ejmech.2011.10.042 |